| Product revenue | |
| Service revenue | |
| Total revenue | 581.7M |
| Costs of product revenue | |
| Costs of service revenue | |
| Total costs of revenue | 397.8M |
| Gross profit | 183.9M |
| Selling, general and administrative expenses | |
| Research and development expenses | 18.6M |
| Transformation costs | |
| Asbestos-related costs, net | |
| Restructuring and asset impairment charges, net | |
| Operating income | 134.8M |
| Interest and non-operating expenses, net | |
| Income from continuing operations before income tax expense | 134.5M |
| Income tax expense | 46.1M |
| Income from continuing operations | 88.4M |
| (Loss) income from discontinued operations, including tax benefit of $0, $7, $1 and $5, respectively | |
| Net income | |
| Continuing operations | 0.99 |
| Discontinued operations | 0.02 |
| Net income | 1.01 |
| Continuing operations | 0.98 |
| Discontinued operations | 0.02 |
| Net income | 1 |
| Weighted average common shares - basic | 89.2M |
| Weighted average common shares - diluted | 89.7M |
| Cash dividends declared per common share | 0.12 |